从1,500,000教师库中查找（输入学校名称或教师姓名）
何玉龙老师介绍
何玉龙 PhD
遗传学，教授，博士生导师
电话
办公室：58641512
实验室：58641522
电子邮件 ：
yhe20005@yahoo.com
yulong.he@nicemice.cn
研究兴趣：
血管新生 (angiogenesis) 与淋巴管新生 (lymphangiogenesis) 的分子调控，以及肿瘤转移的分子机制。
代表论文：
Holopainen T#, Huang H#, Chen C# （co-first author）, Kim KE, Zhang L, Zhou F, Han W, Li C, Yu J, Wu J, Koh GY, Alitalo K, He Y. Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination and establishment. Cancer Res 69:4656-64 (2009). IF: 8.649
Tammela T, He Y(co-first author), Lyytikk? J, Jeltsch M, Markkanen J, Pajusola K, Yl?-Herttuala S, Alitalo K. Distinct Architecture of Lymphatic Vessels Induced by Chimeric Vascular Endothelial Growth Factor-C/Vascular Endothelial Growth Factor Heparin-Binding Domain Fusion Proteins. Circ Res 100:1468-75 (2007). IF: 9.408
He Y, Rajantie I, Pajusola K, Jeltsch M, Holopainen T, Yla-Herttuala S, Harding T, Jooss K, Takahashi T, Alitalo K. VEGFR-3 mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65:4739-46(2005). IF: 8.649
He Y, Rajantie I, Ilmonen M, Makinen T, Karkkainen MJ, Haiko P, Salven P, Alitalo K. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis . Cancer Res 64:3737-40 (2004). IF: 8.649
He Y, Karpanen T and Alitalo K. Role of lymphangiogenic factors in lymphatic tumor metastasis. Biochim Biophys Acta 1654:3-12 (2004). IF: 8.395
He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T, Alitalo K. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94:785-7 (2002). IF: 13.844
He Y, Smith SK, Day KA, Clark D, Licence DR, Charnock-Jones DS. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol 13:537-545 (1999). IF: 5.708
遗传学，教授，博士生导师
电话
办公室：58641512
实验室：58641522
电子邮件 ：
yhe20005@yahoo.com
yulong.he@nicemice.cn
研究兴趣：
血管新生 (angiogenesis) 与淋巴管新生 (lymphangiogenesis) 的分子调控，以及肿瘤转移的分子机制。
代表论文：
Holopainen T#, Huang H#, Chen C# （co-first author）, Kim KE, Zhang L, Zhou F, Han W, Li C, Yu J, Wu J, Koh GY, Alitalo K, He Y. Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination and establishment. Cancer Res 69:4656-64 (2009). IF: 8.649
Tammela T, He Y(co-first author), Lyytikk? J, Jeltsch M, Markkanen J, Pajusola K, Yl?-Herttuala S, Alitalo K. Distinct Architecture of Lymphatic Vessels Induced by Chimeric Vascular Endothelial Growth Factor-C/Vascular Endothelial Growth Factor Heparin-Binding Domain Fusion Proteins. Circ Res 100:1468-75 (2007). IF: 9.408
He Y, Rajantie I, Pajusola K, Jeltsch M, Holopainen T, Yla-Herttuala S, Harding T, Jooss K, Takahashi T, Alitalo K. VEGFR-3 mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65:4739-46(2005). IF: 8.649
He Y, Rajantie I, Ilmonen M, Makinen T, Karkkainen MJ, Haiko P, Salven P, Alitalo K. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis . Cancer Res 64:3737-40 (2004). IF: 8.649
He Y, Karpanen T and Alitalo K. Role of lymphangiogenic factors in lymphatic tumor metastasis. Biochim Biophys Acta 1654:3-12 (2004). IF: 8.395
He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T, Alitalo K. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94:785-7 (2002). IF: 13.844
He Y, Smith SK, Day KA, Clark D, Licence DR, Charnock-Jones DS. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol 13:537-545 (1999). IF: 5.708
何玉龙老师相关教学资源
- 南京大学教学资源
- 何玉龙老师课程教学资源
